Company Information
Industry 制造业
Company Introduction 金花企业(集团)股份有限公司是以生物制药、医药物流为主导产业的高科技上市公司.公司现有产品包括生物药品、生化药品、中西药品、保健品等数百种产品,公司主要代表产品有转移因子口服液/胶囊、人工虎骨粉/金天格胶囊、金花联瑭素、倍宗、咳泰、易息晴、优本等.销售网络遍及全国30个省市自治区.2005年公司在中国医药百强企业中连续两年排名41位,人工虎骨粉(国家一类新药,目前全球惟一天然虎骨替代品)项目被列为"国家高技术产业示范项目",公司连续五年获得西安市高新技术产业开发区"明星科技企业"、"纳税先进企业"和"技术贸总收入百强企业"三项荣誉称号。
Main Business 生物制药、旅游开发、影视及软件开发
Legal Representative 邢雅江
Top Executives
董事长:邢雅江
副董事长:邢博越
董事:张朝阳,邢博越,汪星,邢雅江
独立董事:刘晓娟,吴雅婕,赵舸
Top 5 Shareholder
Shareholder name Nature Holding Date
邢博越流通A股19.63%31/03/2024
新余金煜企业管理有限公司流通A股5.04%31/03/2024
南京金伯珠资产管理有限公司-金伯珠和聚四号私募证券投资基金流通A股5.01%31/03/2024
金花企业(集团)股份有限公司回购专用证券账户流通A股4.38%31/03/2024
杜玲流通A股2.94%31/03/2024
Company Secretary 孙明
Solicitors 北京市嘉源律师事务所
Auditors 瑞华会计师事务所(特殊普通合伙)
Tel No 029-88336635
Fax No 029-81778626
Website www.ginwa.com.cn
Email irm@ginwa.com.cn
Company Address
Register: 陕西省西安市高新区科技四路202号
Office: 陕西省西安市高新区高新三路财富中心三期南座40层
Listing Date 12/06/1997
Shares Capital
Shares Capital: 373,270,285
Total A Share: 373,270,285
Listed A Share: 373,270,285
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.110
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 4.389
Market Capitalization(RMB) 2.598B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.